Evidence map›Paper›PMID 10713713›Full record

ArticleOncogene2000

N-terminal determinants of I kappa B alpha necessary for the cytoplasmic regulation of c-Rel.

I Luque, W X Zong, C Chen, C Gélinas

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

I LuqueCenter for Advanced Biotechnology, University of Medicine and Dentistry of New Jersey, New Jersey, NJ 08854-5638, USA.
W X Zong
C Chen
C Gélinas
Johnson University · USEnvironmental and Occupational Health Sciences Institute · US

Funding

TRANS-ACTING FUNCTION OF THE V- AND C-REL ONCOPROTEINSR01CA054999 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI GELINAS, CELINE · 1996 to 2005
$1.6M
TRANS-ACTING FUNCTION OF THE V- AND C-REL ONCOPROTEINSR29CA054999 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI GELINAS, CELINE · 1991 to 1995
–
NCI NIH HHS CA-54999
6 · The paper itself

Abstract

I kappa B alpha is a dual regulator of Rel/NF-kappa B transcription factors. I kappa B alpha retains inactive NF-kappa B dimers in the cytoplasm, and inhibits their DNA-binding and transcriptional activities in the nucleus. Our previous studies identified discrete functional domains in I kappa B alpha responsible for the cytoplasmic and nuclear regulation of c-Rel. Determinants necessary for regulating c-Rel in the nucleus mapped to the central ankyrin domain of I kappa B alpha and a few negatively-charged amino acids that follow in the C-terminal PEST region. In contrast, sequences involved in the cytoplasmic regulation of c-Rel reside in the N-terminal and central ankyrin domains of I kappa B alpha. Here, we present a refined mapping of the N-terminal determinants of I kappa B alpha necessary for the cytoplasmic regulation of c-Rel homodimers. We demonstrate that amino acids 48 - 58 in p40/I kappa B alpha are essential to block the nuclear localization of c-Rel dimers. These data define a region of I kappa B alpha that may be required for optimal masking of the c-Rel NLS, or for the nuclear export of c-Rel/I kappa B alpha complexes. These findings highlight a novel function for the N-terminus of I kappa B alpha in the control of the subcellular localization of Rel/NF-kappa B dimers. Given the implication of deregulated NF-kappa B activity in hematopoietic and solid tumors, our findings predict that certain alterations in this domain of I kappa B alpha may have severe biological repercussions.

Indexed as

I-kappa B ProteinsAnimalsBinding SitesCOS CellsCytoplasmDNADNA-Binding ProteinsHumansMutagenesis, Site-DirectedNF-kappa BNF-KappaB Inhibitor alphaPeptide FragmentsProto-Oncogene Proteins c-relSequence DeletionTrans-ActivatorsTransfectionDNADNA-Binding ProteinsI-kappa B ProteinsNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanPeptide FragmentsProto-Oncogene Proteins c-relTrans-Activators

Identifiers

PMID10713713
OpenAlexW2315889593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.